McDowell Caryn Gordon 4
4 · Revance Therapeutics, Inc. · Filed Jun 17, 2019
Insider Transaction Report
Form 4
McDowell Caryn Gordon
SVP, GC & Secretary
Transactions
- Tax Payment
Common Stock
2019-06-15$10.86/sh−1,383$15,019→ 22,935 total
Footnotes (2)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on June 15, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock award ("RSA") for 16,000 shares. The RSA vests in four equal annual installments from June 15, 2018, subject to Ms. McDowell's Continuous Service (as defined in the Issuer's 2014 Inducement Plan (the Plan)) on each vesting date.
- [F2]The fair market value was determined on June 14, 2019, pursuant to the Plan.